Isoflavones and the prevention and treatment of prostate disease: Is there a role?

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.